Medical Devices Startups

Metis Pharma is an AI-driven biotech company focused on nanomaterial innovation for targeted drug delivery and discovery, developing therapies for oncology, metabolic diseases, autoimmune disorders, and neurodegenerative conditions. The company has developed three core AI platforms: AiLNP for nanoparticle design, AiRNA for mRNA sequence design, and AiTEM for small molecule formulation.

1 investor

Metric Medical Devices develops internal bone fixation implants designed to accelerate healing and reduce non-union complications in orthopedic extremity procedures.

1 investor

Metricwire provides mobile data collection and digital monitoring solutions for clinical research and trials. The platform enables researchers to gather real-world evidence through adaptive protocols while maintaining participant engagement and safety during studies.

1 investor

Metro Vein Centers provides minimally invasive vein treatments using state-of-the-art, ultrasound-guided technology performed by board-certified vein specialists. The practice serves patients seeking personalized treatment plans for venous conditions with a focus on patient-centered care and outcomes.

1 investor

Metyos is developing a wearable medical device for continuous potassium monitoring to support the management of chronic diseases. It targets doctors and health professionals treating complex pathologies by providing continuous biological data on patients' physiological states.

1 investor

Meyra Group is a European manufacturer of wheelchairs and medical mobility supplies. The company serves patients and healthcare systems requiring assistive devices and mobility solutions.

1 investor

MGS manufactures precision plastic components and molding solutions for healthcare, pharmaceutical, medical device, automotive, and electronics industries. The company operates globally with manufacturing facilities across North America, Ireland, and Mexico, offering integrated services from product design through production and assembly.

1 investor

DRS.LINQ develops mHeart, a healthcare technology solution that integrates into clinical workflows to improve patient outcomes and reduce care costs. The platform serves patients, physicians, healthcare systems, and insurers seeking to modernize value-based care delivery and address overutilization in emergency departments.

1 investor

Micellae develops drug delivery formulations designed to enhance solubility and potency across multiple dosage forms for pharmaceutical, wellness, and recreational products. The company offers O2W, a flexible platform enabling manufacturers to create products with tailored release profiles while reducing active ingredient requirements.

1 investor

MagIC is a microbiome research center that investigates the relationship between the human gut microbiome and various health conditions to develop diagnostics and therapeutics. The organization serves healthcare professionals, researchers, and industry partners across Hong Kong and beyond.

1 investor

Microdermics develops a metal, hollow microneedle injection platform intended to replace traditional hypodermic needles for drug delivery. The company targets the biotherapeutics market with a scalable and customizable microneedle technology.

1 investor

Microline Surgical manufactures high-precision open and minimally invasive surgical instruments for the healthcare community.

1 investor

KitoTech Medical develops microMend, a wound closure product combining microstaples with adhesive backing as an alternative to traditional sutures and staples. The company serves both clinical markets through healthcare networks and hospitals, and consumer markets through retail pharmacy chains and online platforms.

1 investor

Microplate Dx is a diagnostics company developing rapid antimicrobial susceptibility testing technology to identify the correct antibiotic treatment for infections within hours, enabling faster patient treatment and reducing antibiotic resistance. The company targets healthcare providers and focuses on improving clinical outcomes in infectious disease management.

1 investor

Micropoint Technologies is an ISO 13485 certified, cGMP compliant medical device company that develops and manufactures microneedle solutions, including stainless steel, plastic, polymeric, hollow, solid, and custom microneedles. It offers rapid prototyping, product development, and OEM manufacturing, and operates a pilot facility producing clinical batches of dissolving microneedle patches for clinical trials.

1 investor

Micropoint Bio is a microfluidics technology company that develops point-of-care testing (POCT) devices and biochips for clinical diagnostics, including coagulation, cardiac, and infectious disease testing. The company manufactures microfluidic chips and detection instruments for hospitals, laboratories, and clinical settings globally.

1 investor

Microscape provides 3D visualization and viewing tools for microscopy and medical imaging data, with cloud data sharing, remote collaboration, and multi-device access. It serves researchers, professors, graduate students, engineers, care providers, and pharmaceutical/clinical research teams in the research and healthcare fields.

1 investor

The page appears to be a Korean-language medical or healthcare website discussing eye conditions including glaucoma, dry eye skin damage, and optic nerve degeneration, but does not provide clear information about what company operates the site or what products/services it offers.

1 investor

Terumo Neuro (formerly MicroVention) develops minimally invasive catheter-based medical devices for treating neurovascular disorders including cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. The company serves neurovascular surgeons and their patients.

1 investor

MICSI develops AI software that improves MRI image resolution and reduces scanning duration, enabling imaging centers to increase patient capacity. The company aims to enhance MRI technology's diagnostic accuracy through more consistent, quantifiable imaging data.

1 investor

Midwest Vision Partners operates a network of eye care practices across the Midwest, bringing together physicians and support staff to deliver comprehensive vision care services. The platform consolidates practices dating back to the 1940s and supports over 70 locations across five states.

1 investor

Mighty Well designs adaptive medical wear and accessories such as PICC line covers and waterproof protectors for patients living with chronic illnesses and medical devices. It also provides educational resources and a patient community to help people advocate for their own care.

1 investor

Mign designs custom orthopedic braces using digital technology and local manufacturing, replacing mass-produced solutions with personalized care for patients and healthcare providers.

1 investor

Miist develops inhaled microparticle therapies designed to deliver systemic medication to the bloodstream within about 30 seconds, targeting conditions such as migraine, pain, and nausea. Its lead product, MST-02, is a migraine inhaler being advanced into a Phase 1/2 clinical trial.

1 investor